Biomarker-based Immunoassays Market is segmented by Sample Type (Blood, Tissue, Urine, and Others), Product (Reagents & Kits, Instruments/Analyzers, Services), Biomarker Type (Efficacy & Pharmacodynamic, Predictive/Prognostic, and Others), Disease (Cancer, Cardiovascular, Neurological, and Others), End Use (Hospitals & Clinics, Diagnostic Labs, Research), and Region. Forecast for 2026 to 2036.
Get Free Access to Report Sample
The most complete guide to Biomarker-based Immunoassays Market in 2026